ABC | Volume 114, Nº5, Maio 2020

Posicionamento Posicionamento da Sociedade Brasileira de Cardiologia para Gravidez e Planejamento Familiar na Mulher Portadora de Cardiopatia – 2020 Arq Bras Cardiol. 2020; 114(5):849-942 92. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) CollaborativeGroup. Lancet. 1994;343(8898):619-29. 93. Yarrington CD, Valente AM, Economy KE. Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents. Circulation. 2015;132(14):1354-64. 94. Tello-Montoliu A, Seecheran NA, Angiolillo DJ. Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice. J Thromb Thrombolysis. 2013;36(3):348-51. 95. D'Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509-16. 96. VanHagen IM, Roos-Hesselink JW, Ruys TP, MerzWM, Goland S, Gabriel H, et al. Pregnancy inWomenWith aMechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy andCardiacDisease (ROPAC). Circulation. 2015;132(2):132-42. 97. SillesenM, Hjortdal V, VejlstrupN, Sørensen K. Pregnancy with prosthetic heart valves. 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40(2):448-54. 98. Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2014; 18(6):797-806. 99. Basu S, Aggarwal P, Kakani N, Kumar A. Low-dosematernal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106(2):142-7. 100. Ginsberg JS1, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch InternMed. 2003;163(6):694-8. 101. ChanWS, Anand S, Ginsberg JS. Anticoagulation of pregnant womenwith mechanical heart valves: A systematic reviewof the literature. Arch Intern Med. 2000;160(2):191-6. 102. Knol HM, Schultinge L, Erwich JJ, Meijer K. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost. 2010;8(8):1876-9. 103. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al. National Lipid Association recommendations for patient- centered management of dyslipidemia: Part 2. J Clin Lipidol. 2015;9(6 Suppl):S1–122.e1. 104. Karalis DG, Hill AN, Clifton S,Wild RA. The risks of statin use in pregnancy: A systematic review. J Clin Lipidol. 2016;10(5):1081-90. 105. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of firsttrimester statin exposure. N Engl J Med. 2004;350(15):1579-82. 106. Bateman BT, Hernandez-Diaz S, Fischer MA, Seely EW, Ecker JL, Franklin JM, et al. Statins and congenital malformations: cohort study. BMJ. 2015 Mar;350:h1035. 107. Hemnes AR, Kiely DG, Cockrill BA, Safdar Z,Wilson VJ, Al Hazmi M, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015;5(3):435-65. 108. Nelson-Piercy C. Pre-pregnancy counselling. Curr Obstet Gynaecol. 2003;13(5):273-80. 109. Hagan JF Jr, Balachova T, Bertrand J, Chasnoff I, Dang E, Fernandez-Baca D, et al. Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure. Pediatrics. 2016;138(4). pii: e20151553. 110. Aune D, Saugstad OD, Henriksen T, Tonstad S. Physical activity and the risk of preeclampsia: a systematic reviewandmeta-analysis. Epidemiology. 2014;25(3):331-43. 111. Poyatos-León R, García-Hermoso A, Sanabria-Martínez G, Álvarez-Bueno C, Sánchez-López M, Martínez-Vizcaíno V. Effects of exercise during pregnancy on mode of delivery: a meta-analysis. Acta Obstet Gynecol Scand. 2015;94(10):1039-47. 112. American College of Obstetricians andGynecologists. ACOGCommittee Opinion Não. 650: Physical Activity and Exercise During Pregnancy and the Postpartum Period. Obstet Gynecol. 2015;126(6):e135-42. 113. Nutrition and Lifestyle for a Healthy Pregnancy Outcome. Practice Paper of the Academy of Nutrition andDietetics .2014. [Internet] [Cited in 2015 Jan 10]. Available from: //www.eatright. org/members/practicepapers. 114. Mahomed K. Folate supplementation in pregnancy. Cochrane Database Syst Rev.2000;(2):CD000183. 115. Khaing W, Vallibhakara SA, Tantrakul V, Vallibhakara O, Rattanasiri S, McEvoyM, et al. Calciumand VitaminD Supplementation for Prevention of Preeclampsia: A Systematic Review and Network Meta-Analysis. Nutrients. 2017;9(10). pii: E1141. 116. Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, et al. Maternal fish consumption, hair mercury, and infant cognition in a U. S. Cohort. Environ Health Perspect. 2005;113(10):1376. 117. Klebanoff MA, Harper M, Lai Y, Thorp J Jr, Sorokin Y, Varner MW, et al. Fish consumption, erythrocyte fatty acids, and pretermbirth. National Institute of Child Health and Human Development (NICHD). Maternal-Fetal MedicineUnits Network (MFMU). Obstet Gynecol. 2011;117(5):1071-7. 118. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018 Nov;11:CD003402. 119. American College of Obstetricians andGynecologists. ACOGCommittee Opinion Não. 462: Moderate caffeine consumption during pregnancy. Obstet Gynecol. 2010;116(2 Pt 1):467-8. 120. Larsen AD, Hannerz H, Thulstrup AM, Bonde JP, Obel C, Hougaard KS. Psychosocial job strain and risk of congenital malformations in offspring-a DanishNational cohort study. BJOG. 2014;121(7):830-8; discussion 839. 121. Direitos.Brasil. [Internet]. [Citado em2018 jan 12]. Disponível em:https:// direitosbrasil.com 122. Thorne S, Mac gregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92(10):1520-25. 123. Robertson JE, Silversides CK, MahML, Kulikowski J, Maxwell C,Wald RM, et al. A contemporary approach to the obstetric management of women with heart disease. J Obstet Gynaecol Can. 2012;34(9):812-9. 124. Campanharo FF, Cecatti JG, Haddad SM, Parpinelli MA, BornD, CostaML, etal.The ImpactofCardiacDiseasesduringPregnancyonSevereMaternal Morbidity and Mortality in Brazil. Plos One. 2015;10(12):e0144385. 125. Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B, et al. Is a planned caesarean section inwomenwith cardiac disease beneficial? Heart. 2015;101(7):530-6. 126. Oron G, Hirsch R, Ben-Haroush A, Hod M, Gilboa Y, Davidi O, et al. Pregnancy outcome in women with heart disease undergoing induction of labour. BJOG. 2004;111(7):669-75. 127. Ramsey PS, Hogg BB, Savage KG, Winkler DD, Owen J. Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy. Am J Obstet Gynecol. 2000;183(5):1100-2 128. Cauldwell M, Steer PJ, Swan L, Uebing A, Gatzoulis MA, JohnsonMR. The management of the third stage of labour in women with heart disease. Heart. 2017;103(12):945-51. 129. Cauldwell M, Von Klemperer K, Uebing A, Swan L, Steer PJ, Gatzoulis M, et al. Why is post-partum haemorrhage more common in women with congenital heart disease? Int J Cardiol. 2016 Sep;218:285-90. 130. LimG,FaccoFL,NathanN,Waters JH,WongCA,EltzschigHK.AReviewof the Impact of Obstetric Anesthesia onMaternal andNeonatal Outcomes. Anesthesiology. 2018;129(1):192-215. 933